HoloMonitor Fluorescence Now at Novo Nordisk

Phase Holographic Imaging (PHI) recently installed a fluorescence-equipped HoloMonitor® system at Novo Nordisk A/S. The installation is part of a series of test installations to allow experienced HoloMonitor customers to provide feedback regarding functionality and user-friendliness prior to the upcoming product launch.

Fluorescence microscopy is an essential tool used by cell biologists to study the genetic activity of cells. However, fluorescence microscopy is harmful to the cells, making it difficult to study genetic activity over time. PHI solves this dilemma by combining holography with fluorescence microscopy.

A fluorescence equipped HoloMonitor system operating inside a cell incubator at Novo Nordisk A/S
A fluorescence equipped HoloMonitor system operating inside a cell incubator at Novo Nordisk A/S.

“HoloMonitor is perfectly suited for our cell cultures in flow applications as well as many other types of experiments where tracking cell behavior and motility in real-time is a must. To study cell samples in the incubator using fluorescence is a necessary next step for our research.”

― Markus Bosteen, Senior Scientist at Novo Nordisk, Copenhagen (right)

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
Sweden
+46 46 38 60 80
info@phiab.se

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
USA
+1 617-963-5150
info@phiab.com

Invoicing

VAT: SE556542781101
faktura@phiab.se

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2